Kuster Votes in Favor of Legislation to Lower Prescription Drug Costs, Protect Access to Healthcare
Washington, DC, May 16, 2019
Today, Congresswoman Annie Kuster (NH-02) voted in favor of H.R. 987, the Strengthening Health Care and Lowering Prescription Drug Costs Act, which passed the House. The legislation includes three bills that would make prescription drugs more affordable by helping lower-priced generic drugs get to market faster and four measures that would safeguard protections for people with pre-existing conditions and increase the number of Americans enrolled in quality, affordable health coverage. The bill is a critical component of the House Democrats’ For the People Agenda.
“People in New Hampshire and across the country made clear in 2018 that they want Congress to work to improve our healthcare system and abandon partisan attacks on their care,” said Kuster. “This legislation will deliver on our promises to the American people by lowering the costs of care and prescription drugs and increasing access to affordable, quality health insurance. These efforts are gaining support from some Republicans in the House and it’s time for Senator McConnell to put the American people ahead of his partisan agenda to sabotage the Affordable Care Act and bring our legislation up for a vote.”
The bipartisan legislative package includes the following drug pricing measures to remove barriers to lower-priced generic drugs getting to market:
The package also includes the following four measures to improve our health care system, reinforce protections for pre-existing conditions, and expand the number of individuals with quality, affordable health coverage:
Kuster has been vocal about the need to reduce the costs of prescription drugs and hascalled for the direct negotiation of Medicare Part D with pharmaceutical companies to reduce prices. Kuster has made clear the need to make improvements to the Affordable Care Act and preserve protections for people with pre-existing conditions, introducing the Protecting Americans with Preexisting Conditions Act, which passed the House last week. This legislation would revoke guidance issued by the Trump Administration in October 2018 that encourages states to approve health plans that do not cover preexisting conditions.